November 13, 2025: BCMA-Directed Bispecific Antibodies in Multiple Myeloma: Bridging Academic and Community Practice

November 13, 2025

Welcome to the third session of our ECHO program!

BCMA-Directed Bispecific Antibodies in Multiple Myeloma: Bridging Academic and Community Practice

Target Audience:
Oncologists, hematologists, PAs, NPs, nurses, nurse navigators, pharmacists and other healthcare professionals (HCPs) responsible for the care and treatment of people living with RRMM.

Please click on: Take Course the day of the session to access the zoom link.

Learning Objectives:

  • Define the role of academic centers and community practices in providing BCMA targeting BsABs
  • Summarize the importance and benefits of Communities of Practice (CoPs) to providing coordinated, multidisciplinary, and interprofessional care for patients with MM receiving BCMA-directed BsAbs
  • Appropriately incorporate BCMA-directed BsAbs into cases of patients with MM that are representative of clinical practice



Grantor Acknowledgement
This activity is supported by educational grants from Pfizer Inc. and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Course summary
Available credit: 
  • 1.00 AAPA Category I CME
  • 1.00 ABIM Medical Knowledge
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC
    • 1.00 ANCC Pharmacology
  • 1.00 Participation
Course opens: 
06/02/2025
Course expires: 
01/12/2026
Event starts: 
11/13/2025 - 7:00pm EST
Event ends: 
11/13/2025 - 8:00pm EST
Part of: 
ECHOing Excellence: MALSD/MASH Made Manageable in Primary Care (TEST)
Add to calendar: 
Rating: 
0

  Camille Edwards, MD
  Assistant Professor of Medicine
  Boston University Chobanian & Avedisian School of Medicine
  Boston Medical Center
  Boston, MA

  Camille Edwards, MD, is an assistant professor of medicine at the Boston University Chobanian & Avedisian School of Medicine (BUSM )and Boston Medical Center (BMC). After  internal medicine residency, Edwards completed her hematology and oncology fellowship at BUSM/BMC, obtaining rigorous clinical and research training through the comprehensive Cancer Center, the world-renowned BU Amyloidosis Center, and the Center for Regenerative Medicine. As a physician-scientist and hematologist, her clinical and research platforms are multifaceted. In her clinical capacity, she not only provides care for patients with hematologic diseases but also advocates for patients through peer education and community-based patient education programs. Her translational research focuses on deciphering the socioenvironmental and molecular context of plasma cell disorders. Edwards’s work has led to several prestigious awards from the American Society of Hematology, the International Myeloma Foundation, and the National Institutes of Health's Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Researcher Diversity.

Dr. Camille Edwards has no relevant financial relationships to disclose.

 

Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.

Accreditation Statement
This activity is developed as a joint collaboration among Boston University Chobanian & Avedisian School of Medicine, Med-IQ, the AAPA, the Association of PAs in Oncology (APAO), and HealthTree Foundation.


In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and Med-IQ. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.



Physician Accreditation
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

 

   American Board of Internal Medicine Maintenance of Certification (MOC) Part 2 Credit

   Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal  Medicine’s (ABIM)  Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the ABIM.



Nurse Accreditation
Nursing Contact Hours: 1.0, of which 1.0 is eligible for pharmacology credit.

 



Pharmacist Accreditation
This activity is approved for 1.0 CPE credit.



​​​​
Physician Associate Accreditation
Boston University Chobanian & Avedisian School of Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 1.00 AAPA Category I CME
  • 1.00 ABIM Medical Knowledge
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC
    • 1.00 ANCC Pharmacology
  • 1.00 Participation
Please login or register to take this course.


Thank you for registering for our first session!

Once you have participated in the meeting, click on the link provided in the chat or in your calendar invite to come back here. Click on "Take Course" above to complete the evaluation and claim credit.

Please contact [email protected] with any questions of if you need assistance.